Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular Cancer Therapeutics|October 22, 2017
Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1)Matthew Sung, Xingzhi Tan, Bingwen Lu, et al.
Cancer Research|June 17, 2005
SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft modelsJennifer M Golas, Judy Lucas, Carlo Etienne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint InhibitorsChanghua Ji, Marc D Roy, Jonathan Golas, et al.
Cancer Immunology, Immunotherapy : CII|October 26, 2017
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in miceTimothy S Fisher, Andrea T Hooper, Justin Lucas, et al.
Cancer Research|June 3, 2004
Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinaseSridhar K Rabindran, Carolyn M Discafani, Edward C Rosfjord, et al.
Journal of Medicinal Chemistry|February 18, 2005
Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activityHwei-Ru Tsou, Elsebe G Overbeek-Klumpers, William A Hallett, et al.
Molecular Imaging and Biology|June 18, 2021
Preclinical Evaluation of <sup>89</sup>Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging TherapyKevin P Maresca, Jianqing Chen, Divya Mathur, et al.
Gastroenterology|August 20, 2020
Cooperation Between Distinct Cancer Driver Genes Underlies Intertumor Heterogeneity in Hepatocellular CarcinomaPedro Molina-Sánchez, Marina Ruiz de Galarreta, Melissa A Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal CancersDivya Mathur, Adam R Root, Bozena Bugaj-Gaweda, et al.
Molecular Cancer Therapeutics|May 14, 2025
A Novel B7-H4xCD3 Bispecific T Cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune-Checkpoint TherapiesKeith Abayasiriwardana, Lei Wu, Hanane Laklai, et al.
Pageof 1